Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amag Pharmaceuticals (AMAG)

Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 477,469
  • Shares Outstanding, K 34,725
  • Annual Sales, $ 327,750 K
  • Annual Income, $ -466,460 K
  • 60-Month Beta 0.89
  • Price/Sales 1.45
  • Price/Cash Flow N/A
  • Price/Book 1.85
Trade AMAG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.30
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 11/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.01
  • Number of Estimates 4
  • High Estimate 0.11
  • Low Estimate -0.13
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +102.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.35 +3.00%
on 10/14/20
13.76 -0.07%
on 11/13/20
+0.38 (+2.84%)
since 10/13/20
3-Month
8.62 +59.51%
on 09/24/20
13.80 -0.36%
on 10/01/20
+3.18 (+30.09%)
since 08/13/20
52-Week
4.41 +211.79%
on 03/18/20
13.80 -0.36%
on 10/01/20
+4.06 (+41.90%)
since 11/13/19

Most Recent Stories

More News
Sensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent Director

Regulatory News:

DVAX : 12.41 (unch)
HARP : 23.01 (+0.09%)
AMAG : 13.75 (+0.15%)
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

WARREN, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’...

AQST : 4.26 (+3.90%)
FRLN : 6.48 (unch)
AMAG : 13.75 (+0.15%)
VRTX : 418.01 (+0.17%)
SYK : 357.87 (-0.23%)
SCYX : 1.4700 (+3.16%)
ABBV : 182.10 (+0.97%)
DCTH : 4.77 (-6.29%)
NRX : 0.14 (+7.69%)
AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)

WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal...

AMAG : 13.75 (+0.15%)
Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., Eaton Vance Corp., MobileIron, Inc., and Seacoast Commerce Banc Holdings

NEW YORK, Oct. 30, 2020 (GLOBE NEWSWIRE) --

AMAG : 13.75 (+0.15%)
EV : 23.98 (-0.13%)
MOBL : 7.04 (+0.07%)
SCBH : 17.2500 (+1.47%)
INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm – AMAG, BMCH, VRTU

NEW YORK, NY / ACCESSWIRE / October 17, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) concerning potential violations of the federal...

AMAG : 13.75 (+0.15%)
BMCH : 53.68 (-3.24%)
VRTU : 51.33 (+0.03%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of AMAG Pharmaceuticals, Inc. Buyout

WILMINGTON, Del., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating AMAG Pharmaceuticals, Inc. (“AMAG”) (NASDAQ GS: AMAG ) regarding possible breaches...

AMAG : 13.75 (+0.15%)
Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), MobileIron, Inc. (NASDAQ GS: MOBL), Seacoast Commerce Banc Holdings (OTC: SCBH), and Perceptron, Inc. (NASDAQ GS: PRCP)

NEW YORK, Oct. 15, 2020 (GLOBE NEWSWIRE) --

AMAG : 13.75 (+0.15%)
MOBL : 7.04 (+0.07%)
SCBH : 17.2500 (+1.47%)
PRCP : 6.98 (+0.07%)
AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients

WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s...

AMAG : 13.75 (+0.15%)
AMAG PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AMAG Pharmaceuticals, Inc. - AMAG

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AMAG Pharmaceuticals, Inc. (NasdaqGS: AMAG)...

AMAG : 13.75 (+0.15%)
Moore Kuehn Encourages GLIBA, WPX, VRTU, and AMAG Investors to Contact Law Firm

NEW YORK, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...

GLIBA : 91.73 (-2.57%)
WPX : 9.43 (+5.36%)
VRTU : 51.33 (+0.03%)
AMAG : 13.75 (+0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 13.76
1st Resistance Point 13.76
Last Price 13.75
1st Support Level 13.75
2nd Support Level 13.74
3rd Support Level N/A

See More

52-Week High 13.80
Last Price 13.75
Fibonacci 61.8% 10.21
Fibonacci 50% 9.10
Fibonacci 38.2% 8.00
52-Week Low 4.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar